InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-08 · accession 0001209191-21-063952 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-10 2021-11-08 WGS Ro Isaac CFO S - Sale+OE $8.49 -19.5K 127.1K -13% -$165.7K
D 2021-11-10 2021-11-08 WGS Ro Isaac CFO M - OptEx — +62.5K 146.7K +74% —
D 2021-11-10 2021-11-08 WGS Ro Isaac CFO M - OptEx $0.00 -62.5K 812.5K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-11-08 S D 19,516 $8.49 127,136 D — —
2 Common Class A Common Stock 2021-11-08 M A 62,500 — 146,652 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
3 Derivative Restricted Stock Unit 2021-11-08 M D 62,500 $0.00 812,500 D — · — to — 62,500 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.